Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3723747 | 0.96 | LMNA (0.42) | SMN1; SMN2TSHRLMNAALDH1A1HSD17B10 | |
| SCHEMBL7902914 | 0.96 | LMNA (0.42) | SMN1; SMN2TSHRLMNAALDH1A1HSD17B10 | |
| SCHEMBL3676122 | 0.96 | LMNA (0.42) | SMN1; SMN2TSHRLMNAALDH1A1HSD17B10 | |
| SCHEMBL3579746 | 0.96 | LMNA (0.42) | SMN1; SMN2TSHRLMNAALDH1A1HSD17B10 | |
| SCHEMBL18655487 | 0.96 | LMNA (0.42) | SMN1; SMN2TSHRLMNAALDH1A1HSD17B10 | |
| SCHEMBL2458373 | 0.96 | LMNA (0.42) | SMN1; SMN2TSHRLMNAALDH1A1HSD17B10 | |
| SCHEMBL5010989 | 0.93 | TDP1 (0.39) | SMN1; SMN2TSHRLMNAALDH1A1HSD17B10 | |
| Ethylene SCHEMBL7913495 | 0.90 | LMNA (0.38) | SMN1; SMN2TSHRLMNAALDH1A1HSD17B10 | |
| SCHEMBL331112 | 0.88 | TDP1 (0.38) | SMN1; SMN2TSHRLMNAALDH1A1HSD17B10 | |
| SCHEMBL8368422 | 0.86 | TSHR (0.37) | SMN1; SMN2TSHRLMNAALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120082281-A | Preparation method of two-dimensional porous double transition metal oxide composite self-repairing noise-reducing anticorrosive coating | 中国海洋大学 | 2025-06-03 | — | — | CN | claimed |
| CN-118879155-A | Heavy-duty anticorrosive powder coating based on waste polyester fibers and preparation method thereof | 宁波市七彩塑粉有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-118221906-A | Isocyanate-terminated prepolymer, polyurethane, self-repairing polyurethane coating, and preparation method and application thereof | 比亚迪股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-109072438-B | Methods of depositing a metal or metal alloy onto a substrate surface and including substrate surface activation | 德国艾托特克公司 | 2021-08-13 | — | — | CN | claimed |
| US-10975474-B2 | Process for depositing a metal or metal alloy on a surface of a substrate including its activation | ATOTECH DEUTSCHLAND GMBH (DE) | 2021-04-13 | — | — | US | claimed |
| EP-3452635-B1 | PROCESS FOR DEPOSITING A METAL OR METAL ALLOY ON A SURFACE OF A SUBSTRATE INCLUDING ITS ACTIVATION | ATOTECH DEUTSCHLAND GMBH (DE) | 2020-02-26 | — | — | EP | claimed |
| US-20190169751-A1 | PROCESS FOR DEPOSITING A METAL OR METAL ALLOY ON A SURFACE OF A SUBSTRATE INCLUDING ITS ACTIVATION | ATOTECH DEUTSCHLAND GMBH & CO. KG (F/K/A ATOTECH DEUTSCHLAND GMBH) (DE) | 2019-06-06 | — | — | US | claimed |
| EP-3452635-A1 | PROCESS FOR DEPOSITING A METAL OR METAL ALLOY ON A SURFACE OF A SUBSTRATE INCLUDING ITS ACTIVATION | ATOTECH Deutschland GmbH (DE) | 2019-03-13 | — | — | EP | claimed |
| US-20250213478-A1 | CATIONIC LIPID HAVING DISULFIDE BOND, LIPID MEMBRANE STRUCTURE INCLUDING SAME, NUCLEIC ACID INTRODUCTION AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING ANY ONE OF SAME, METHOD FOR INTRODUCING NUCLEIC ACID INTO CELL OR TARGET CELL, AND METHOD FOR PRODUCING CELLULAR PHARMACEUTICAL | NOF CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250205168-A1 | METHOD FOR PRODUCING NUCLEIC ACID-ENCAPSULATED LIPID NANOPARTICLES, METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION CONTAINING SAID LIPID NANOPARTICLES, AND METHOD FOR INTRODUCING NUCLEIC ACID INTO CELL OR TARGET CELL | NOF CORPORATION (JP) | 2025-06-26 | — | — | US | disclosed |
| CN-118879155-B | Heavy-duty anticorrosive powder coating based on waste polyester fibers and preparation method thereof | 宁波市七彩塑粉有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-120082281-A | Preparation method of two-dimensional porous double transition metal oxide composite self-repairing noise-reducing anticorrosive coating | 中国海洋大学 | 2025-06-03 | — | — | CN | disclosed |
| EP-4506337-A1 | CATIONIC LIPID HAVING DISULFIDE BOND, LIPID MEMBRANE STRUCTURE INCLUDING SAME, NUCLEIC ACID INTRODUCTION AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING ANY ONE OF SAME, METHOD FOR INTRODUCING NUCLEIC ACID INTO CELL OR TARGET CELL, AND METHOD FOR PRODUCING CELLULAR PHARMACEUTICAL | NOF Corporation (JP) | 2025-02-12 | — | — | EP | disclosed |
| EP-4501317-A1 | METHOD FOR PRODUCING NUCLEIC ACID-ENCAPSULATED LIPID NANOPARTICLES, METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION CONTAINING SAID LIPID NANOPARTICLES, AND METHOD FOR INTRODUCING NUCLEIC ACID INTO CELL OR TARGET CELL | NOF Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| EP-2115033-A1 | POLYURETHANE | Societe de Technologie Michelin (FR) | 2009-11-11 | — | — | EP | disclosed |
| WO-2008077151-A1 | POLYURETHANE | SOCIETE DE TECHNOLOGIE MICHELIN (FR) | 2008-06-26 | — | — | WO | disclosed |
| EP-0552376-B1 | PRODUCTION OF POLYMER HYDROXYLATED AT BOTH TERMINALS, COMPOSITION CONTAINING SAID POLYMER AND ITS USE, AND POLYMER DERIVED FROM SAID COMPOSITION AND ITS USE | NIPPON CATALYTIC CHEM IND (JP) | 1999-01-13 | — | — | EP | disclosed |
| US-5391665-A | Catalyzed polymerization in the presence of a dihydroxypolysulfide compound | NIPPON SHOKUBAI CO., LTD. (JP) | 1995-02-21 | — | — | US | disclosed |
| EP-0552376-A1 | PRODUCTION OF POLYMER HYDROXYLATED AT BOTH TERMINALS, COMPOSITION CONTAINING SAID POLYMER AND ITS USE, AND POLYMER DERIVED FROM SAID COMPOSITION AND ITS USE | NIPPON SHOKUBAI CO., LTD. (JP) | 1993-07-28 | — | — | EP | disclosed |
| US-4721813-A | Method for the oxidation of mercaptoalkanols to dithiodiglycols | PHILLIPS PETROLEUM COMPANY (US) | 1988-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250213478-A1 | CATIONIC LIPID HAVING DISULFIDE BOND, LIPID MEMBRANE STRUCTURE INCLUDING SAME, NUCLEIC ACID INTRODUCTION AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING ANY ONE OF SAME, METHOD FOR INTRODUCING NUCLEIC ACID INTO CELL OR TARGET CELL, AND METHOD FOR PRODUCING CELLULAR PHARMACEUTICAL | SGMS1, LNPK, SLC27A1 | SMN1; SMN2 1155/4885TSHR 2113/4885LMNA 812/4885 |
| US-20250205168-A1 | METHOD FOR PRODUCING NUCLEIC ACID-ENCAPSULATED LIPID NANOPARTICLES, METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION CONTAINING SAID LIPID NANOPARTICLES, AND METHOD FOR INTRODUCING NUCLEIC ACID INTO CELL OR TARGET CELL | NPC1L1, LIPA, NPC1 | SMN1; SMN2 2531/4885TSHR 3356/4885LMNA 20/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.